T cells expressing chimeric antigen receptors can cause anaphylaxis in humans. - Wikidata - wikimedia - TriplyDB

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

http://www.wikidata.org/entity/Q37466219

about

CAR models: next-generation CAR modifications for enhanced T-cell function New Strategies for the Treatment of Solid Tumors with CAR-T Cells Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors The Evolution of T-cell Therapies for Solid Malignancies Genetically modified T cells for the treatment of malignant disease Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection High-content molecular profiling of T-cell therapy in oncology Technical Considerations for the Generation of Adoptively Transferred T Cells in Cancer Immunotherapy Toxicity and management in CAR T-cell therapy T cell engineering as therapy for cancer and HIV: our synthetic future Smart CARs engineered for cancer immunotherapy Designing chimeric antigen receptors to effectively and safely target tumors In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma.Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies.Immunotherapy: opportunities, risks and future perspectives Back to the future! The evolving role of maintenance therapy after hematopoietic stem cell transplantation.A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer.Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma Seatbelts in CAR therapy: How Safe Are CARS?Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer.Fully human CD19-specific chimeric antigen receptors for T-cell therapy.A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity.Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastoma Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity.Chimeric antigen receptor-modified T cells strike back.Toxicities of chimeric antigen receptor T cells: recognition and management.Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value.Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.Design and development of therapies using chimeric antigen receptor-expressing T cells

P2860

Q26745600-41040D82-488B-499B-8F10-12DCB1BAD85B Q26748500-DC41F9BF-6018-41F5-A535-573A1D8322DE Q26753082-5AB10074-613F-483C-B8D5-0A6F7D34F4C7 Q26773309-90CBD6F8-0A22-427C-BBB7-761BC480F86F Q26778759-660D5B9D-D555-4063-AB26-63A4ADD8629D Q26799372-54022B37-18A2-42BB-95AA-4E64C41B5EFE Q26860657-288EA92C-3EF7-422A-8EEB-3798242890B3 Q27005830-A81B61D9-29DF-4BD0-8684-F85C4019F9DA Q28066792-65D4247F-1494-40D9-8D60-78EBDC43C1EE Q28073563-1446A661-8A6F-4456-94D6-2DBAFD6BD0F2 Q28075314-CADE7FBD-9145-4D15-9233-0988EA6443C3 Q28082253-17D1D0B0-945D-47C5-B6F4-1B8654FE84BC Q28087236-BFDB3C49-BC5C-407A-A731-BFA7E89CCAB8 Q28088526-515185C9-BC3E-4B93-8AC7-091CC059AF79 Q28554677-C4295BC8-3709-4EAA-9ED6-F8D5A65428D8 Q33561644-CFC5E463-62D6-42A7-9DB9-C84F286D1797 Q33776367-D22DEE3B-E6FC-4D15-A8B8-53C79ACFB4A7 Q33940443-92FA7B07-C97B-439A-B7B2-126FAFB69C72 Q33941012-9AB4219D-9A40-448C-86C3-6E75BA038DE3 Q34380489-06AA0797-E559-4811-8490-E7D862ABB056 Q34729692-B94F7201-07FD-4E13-9237-1726D5250170 Q35216278-4B05CF5C-F62B-43E7-A913-43E3C1674BF4 Q35661999-2B3CA4A3-08C3-4637-ACFA-457EC1B13337 Q35741739-FA0318BD-E193-4F9F-9A4A-BA6D8816D594 Q35818365-AC2AB60A-099F-4CBD-9695-9A9728F61B7E Q35980893-0DCBE470-6FE8-4C01-AA1B-D9150C71DE83 Q36281920-679D0B17-E3DC-453A-B7E3-C841A79E3268 Q36356392-42F069A3-8F29-49C1-B1D9-F428C7DEE3F6 Q36474226-38B7A561-017B-4D2A-A352-6D8E1BC7A02F Q36557169-44661B38-9E2B-494C-8CC3-082ED4AC1FB9 Q36777093-B107E153-AE6C-4D80-B1FF-14BCE5B35496 Q36781992-469E0BE5-0066-427D-B6B9-710EB1576C7F Q36830759-86CE5E74-2FEB-4F06-A3CC-CEEC1BE50EA3 Q36957716-81A7F26A-F27C-439C-870B-1DBD8E06BE9A Q37040370-AED133DC-3162-451C-B3BE-0DA0FE291632 Q37058104-60E269D9-26AD-4243-ADAF-D7B57E4AB790 Q37135340-C06E8B80-4F04-4470-B356-D6DEB195A654 Q37193096-71A5CE62-C018-4AB2-BCE0-AE12D9F86D16 Q37257207-E7F178B0-9FCC-4758-B1C3-514BDDC6B124 Q37418289-CBC07CD1-5FFE-4D86-8B82-0A30C37E2568

P2860

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

http://www.wikidata.org/entity/Q37466219

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

@en

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

@nl

type

label

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

@en

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

@nl

prefLabel

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

@en

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

@nl

P1433

Q37466219-891B295F-8EFA-4F27-91EB-5E31BC6FFA00

P1476

Q37466219-196781F3-6A75-463B-9F52-A05FDDB276C7

P2093

Q37466219-1F40CC05-74DA-49EE-89CE-6CFA4361FE4F

Q37466219-3D6DBF81-CB1F-4059-ADAE-709591D01D1C

Q37466219-7521A424-389C-4E50-B630-E4E7F620047C

Q37466219-78A1B671-571B-427F-9FD6-EA48962EE261

Q37466219-81639ACC-0321-438C-B953-C214971E6B2A

Q37466219-94820BAB-B203-43A5-9EB2-FB863EF43C4B

Q37466219-D038F195-1B94-4627-8298-122FF4E56E8B

Q37466219-FB824341-91EF-416E-B7E2-C6E63F6F68F0

P2860

Q37466219-08370FB6-E9A6-452C-8247-8066485BA3E0

Q37466219-217C2C1F-DB5E-4E38-8692-298BC16AB073

Q37466219-21ED6B7A-072D-444A-AF06-3F9ECF000586

Q37466219-337F511C-64C3-4530-B8DC-B3BCAC48C405

Q37466219-390E32DD-B21C-429B-8BAE-ED56E1C395B3

Q37466219-3BFB1EF1-92C1-4871-AB3D-6A4FA8AC8BA2

Q37466219-46B2A39E-278E-4732-BA48-4B9CE7EBAB62

Q37466219-5986D42B-862B-4208-AEA9-A99D65CB126C

Q37466219-618F0873-C107-40E2-81DB-EB7C145C9A13

Q37466219-62B2E1D5-FF82-4D8A-9C87-20E4B0458F77

P304

Q37466219-D8FF6B71-5A73-43AF-9BB5-C2C1CCD48473

P31

Q37466219-FE8A1A0D-4B92-4E72-9791-CEDE80F02B8D

P356

Q37466219-55FB91D2-357C-4117-9461-3A1230FE8D55

P478

Q37466219-363DFAD9-7AAA-489A-8862-A7E43090CD33

P50

Q37466219-AA83B8B7-42B6-46F1-A858-C6FB1646AF3D

P577

Q37466219-DCC5C641-786D-4C45-8758-0880183F61C9

P698

Q37466219-47E223F6-8F37-45F4-B871-BC7D714E9F4F

Q37466219-9e757693-ef48-4ecc-b7ef-daf20c11733f

P921

Q37466219-B0AF0658-F3D3-4C9C-B45B-C69D2A5EB838

P932

Q37466219-5E1CD981-CDFB-4896-99FF-E1B0E540566C

P356

2326-6066.CIR-13-0006

P1433

Cancer immunology research

P1476

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans

@en

P2093

Andrew R Haas

http://www.w3.org/2001/XMLSchema#string

Bruce L Levine

http://www.w3.org/2001/XMLSchema#string

Carl H June

http://www.w3.org/2001/XMLSchema#string

Marcela V Maus

http://www.w3.org/2001/XMLSchema#string

Michael Kalos

http://www.w3.org/2001/XMLSchema#string

Steven M Albelda

http://www.w3.org/2001/XMLSchema#string

Xiaojun Liu

http://www.w3.org/2001/XMLSchema#string

Yangbing Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium

A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.

Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.

Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials.

Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.

Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor

P304

26-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2326-6066.CIR-13-0006

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Gregory L Beatty

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24432303

http://www.w3.org/2001/XMLSchema#string

P921

P932

3888798

http://www.w3.org/2001/XMLSchema#string